or Try an Advanced Search...

    Technical Analysis for MSB - Mesoblast limited  

    Grade Last Price % Change Price Change
    B 0.770 -7.23% -0.060
    MSB closed down 7.23 percent on Tuesday, April 16, 2024, on 1.12 times normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Up Up Down
    Historical MSB trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    NR7 Range Contraction -7.23%
    Older End-of-Day Signals for MSB ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR about 10 hours ago
    Down 5% about 11 hours ago
    1.5x Volume Pace about 11 hours ago
    Fell Below Previous Day's Low about 11 hours ago
    Down 3% about 11 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MSB Chart by TradingView
    Basic chart:

    Profile

    Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Disease Diseases Life Sciences Biology Disorders Stem Cell Stem Cells Cell Biology Induced Stem Cells Adult Stem Cell

    Is MSB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 27 Mesoblast (MESO) to File Pediatric GVHD Drug BLA, Stock Up
    Mar 26 After Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious Complications in Children Following Stem Cell Transplant
    Mar 26 United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
    Mar 13 Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer
    Mar 10 United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)
    Mar 3 Mesoblast Limited (NASDAQ:MESO) Q2 2024 Earnings Call Transcript
    Feb 29 Mesoblast First Half 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Feb 28 Mesoblast Reports Financial Results and Operational Update for Half-Year Ended December 31, 2023
    Feb 26 Mesoblast Financial Results and Corporate Update Webcast
    Feb 15 United States Food & Drug Administration (FDA) Grants Mesoblast Orphan-Drug Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
    See more MSB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.425
    52 Week Low 0.255
    Average Volume 10,901,784
    200-Day Moving Average 0.488
    50-Day Moving Average 0.444
    20-Day Moving Average 0.659
    10-Day Moving Average 0.870
    Average True Range 0.066
    RSI (14) 61.83
    ADX 59.68
    +DI 38.215
    -DI 19.200
    Chandelier Exit (Long, 3 ATRs) 0.777
    Chandelier Exit (Short, 3 ATRs) 0.523
    Upper Bollinger Bands 1.159
    Lower Bollinger Band 0.159
    Percent B (%b) 0.61
    BandWidth 151.654
    MACD Line 0.134
    MACD Signal Line 0.135
    MACD Histogram -0.0006
    Fundamentals Value
    Market Cap 452.44 Million
    Num Shares 588 Million
    EPS -0.18
    Price-to-Earnings (P/E) Ratio -4.23
    Price-to-Sales 109.07
    Price-to-Book 3.26
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.856
    Resistance 3 (R3) 0.860 0.835 0.842
    Resistance 2 (R2) 0.835 0.813 0.833 0.837
    Resistance 1 (R1) 0.803 0.799 0.790 0.799 0.832
    Pivot Point 0.778 0.778 0.771 0.776 0.778
    Support 1 (S1) 0.745 0.756 0.733 0.741 0.708
    Support 2 (S2) 0.720 0.742 0.718 0.703
    Support 3 (S3) 0.688 0.720 0.698
    Support 4 (S4) 0.684